Superdrol

Superdrol is a brand and street name for methasterone, a 17alpha-methylated anabolic-androgenic steroid with the molecular formula C21H34O2 ^[1]. Structurally it is a derivative of dihydrotestosterone that carries extra methyl groups at the 2alpha and 17alpha positions, formally named 2alpha,17alpha-dimethyl-5alpha-dihydrotestosterone ^[1]. The 17alpha-methyl group lets the molecule survive first-pass breakdown in the liver, which gives it useful oral activity but also contributes to its liver toxicity ^[1][4].

The compound was first synthesized by chemists at Syntex in the mid-1950s during a program exploring steroid analogs, and a 1959 report described it as a potent orally active anabolic agent with comparatively weak androgenic effects ^[1]. It then drew little attention until 2005, when it was introduced to the United States supplement market under the name Superdrol ^[2]. Sold as a dietary supplement rather than a drug, it was promoted as building muscle without hormonal activity, a claim that later clinical case reports directly contradicted ^[2].

Because it was available without a prescription, methasterone reached recreational users seeking rapid gains in muscle mass and strength, and much of the medical literature on it consists of case reports describing harm rather than trials of benefit ^[2][3]. Published cases document cholestatic jaundice, prolonged liver injury, and in one instance IgA nephropathy following use of products containing the steroid ^[2][3]. Anti-doping and analytical laboratories have separately characterized how it is metabolized and excreted so that it can be identified in urine testing ^[4].

Regulators responded as these products spread. Methasterone is now controlled as a Schedule III substance under United States law, and the World Anti-Doping Agency prohibits it in sport, where laboratories screen for its metabolites ^[4]. Despite these controls it has periodically reappeared in grey-market preparations, typically sold as oral tablets or capsules, and it has no recognized medical indication.

Superdrol (methasterone) is an oral 17-alpha-alkylated anabolic-androgenic steroid and is not a legitimate medicine. It is markedly hepatotoxic, with reported cases of cholestatic liver injury and liver failure, and it strongly suppresses the hypothalamic-pituitary-testicular axis, sharply lowers HDL cholesterol while raising blood pressure, and worsens cardiovascular risk. Additional harms include mood changes and aggression, and virilizing effects in women; its use carries serious, well-documented dangers.

Superdrol (methasterone) is an unapproved oral 17-alpha-alkylated anabolic-androgenic steroid with no formal drug label, so its interactions are inferred from the well-documented anabolic-steroid class. Like other 17-alpha-alkylated oral steroids it potentiates the effect of warfarin and other coumarin anticoagulants, raising bleeding risk and requiring reduced anticoagulant dosing, a class interaction described for oxandrolone and methyltestosterone. Its marked hepatotoxicity, including cholestatic injury and peliosis, is additive with other hepatotoxic drugs and alcohol. Anabolic steroids can also increase sensitivity to insulin and oral hypoglycemics and may antagonize the fluid-balance effects of corticosteroids. This is research information, not medical advice.

Checking a whole stack? Run it through interactions + stacks.

Methasterone was first prepared in the 1950s during the intensive era of steroid chemistry, when companies such as Syntex synthesized and characterized large numbers of anabolic-androgenic derivatives of dihydrotestosterone. Early reports described it as having a high anabolic-to-androgenic ratio, yet unlike many of its contemporaries it was never developed or marketed as an approved medicine. The compound resurfaced decades later, around 2005, when it was sold over the counter as a designer steroid and bodybuilding supplement under the name Superdrol, marketed as a legal alternative to prescription anabolics.

Mounting reports of liver injury and its clearly androgenic nature drew regulatory attention, and it was ultimately brought under control as a scheduled anabolic steroid in the United States, a status reinforced by the Designer Anabolic Steroid Control Act of 2014. Analytical studies have since documented methasterone turning up as an undeclared ingredient in products sold as ordinary dietary supplements.

Superdrol carries a reputation within bodybuilding circles as an unusually potent oral compound capable of producing rapid gains in muscle size and strength, and this potency is the basis of its notoriety. In the scientific and medical literature, however, it is far better known as a cautionary example: an orally active 17-alpha-alkylated steroid repeatedly linked to cholestatic liver injury, unfavorable shifts in blood lipids, and suppression of the body's own testosterone.

Its history as a covertly sold designer steroid, sometimes hidden in products labeled as vitamins, has made it a frequent subject of doping-control and public-health investigations. An honest account credits its strong androgen-receptor activity while emphasizing that the same chemical feature enabling oral use is the one most tied to its liver toxicity. It stands today as a controlled substance rather than a legitimate therapeutic agent.